Steffan Joe's Album: Wall Photos

Photo 7 of 8 in Wall Photos

Cancer Biomarkers
Market by Roots Analysis

Advances in biotechnology have enabled the identification
of several novel biomarkers, which are presently being used for a variety of
purposes, including diagnosis, drug development, clinical research and to
facilitate therapy-related decisions

Roots Analysis is pleased to announce the publication of its recent
study, titled, “Cancer
Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing,

The report features an extensive study of the current landscape
and future outlook of the immuno-oncology biomarkers testing market (focusing
particularly on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+)). It provides an
in-depth analysis, highlighting the capabilities of the various companies
engaged in this domain. Amongst various elements, the report includes:

§ A detailed
analysis of ongoing, biomarker-based clinical trials initiated by big
pharmaceutical companies.

§ An
analysis of the landscape of companies offering testing services for cancer
biomarkers, namely TMB, MSI / MMR and TILs (including CD3+, CD4+, CD8+ and

§ An
insightful 2X2 representation of the results of a detailed competitiveness
analysis of various tests (segregated
across different biomarker groups).

§ Elaborate
profiles of leading analytical testing service providers focused on
immuno-oncology biomarkers (shortlisted
based on strength of service portfolio).

§ A
detailed publication analysis of over 180 research articles that have been
published since 2016, highlighting the key focus areas of ongoing research
activity related to immuno-oncology biomarkers, namely TMB, MSI / MMR and TILs.

§ A
comprehensive clinical trial analysis of completed, ongoing and planned
studies, focused on the assessment of cancer biomarkers, namely TMB, MSI / MMR
and TILs.

§ A
discussion on the upcoming opportunities that are likely to impact the
evolution of this market over the coming years.

§ A
discussion on various steps involved in development operations of companion

§ A
comparative analysis of the needs of different stakeholders involved in the
development of companion diagnostic products

§ A detailed market
forecast, featuring analysis of the current and projected future opportunity
across key market segments (listed below)

Type of test

§ Laboratory
Developed Tests (LDTs)

§ Companion
Diagnostic Tests (CDx)

Type of disease indication

§ Breast

§ Blood

§ Colon
/ Colorectal cancer

§ Lung

§ Melanoma

§ Prostate

Type of cancer biomarker



§ TILs

Type of analytical technique

§ Next
Generation Sequencing (NGS)

§ Polymerase
Chain Reaction (PCR)

§ Immunohistochemistry

§ Others

Key geographical regions

§ North

§ Europe

§ Japan

§ China

§ Australia

companies covered in the report

Foundation Medicine

NeoGenomics Laboratories


Q2 Solutions

Personal Genome Diagnostics

Dr Lal PathLabs

Shenzhen Yuce Biotechnology

more information please click on the following link:

Other Recent Offerings

Global T-Cell (CAR-T,
TCR, and TIL) Therapy Market (4th Edition), 2019-2030

Neoantigen Targeted
Therapies Market,

Companion Diagnostics
(2nd Edition), 2019-2030

Cell Encapsulation: Focus on Therapeutics
and Technologies, 2019-2030

In Vitro ADME Testing
Services Market,

About Roots Analysis

Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at

Contact Information

Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Facebook -

LinkedIn -

Twitter -